Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2024-02-23

New treatment for rare motor neurone disease recommended for approval

View source ↗

Summary

The EMA recommends approval for a new treatment aimed at rarer forms of motor neuron disease, indicating a potential new option for patients with the condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications